- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05843396
Brain Organization, Development, and Response to Intervention in Individual Neonates
August 17, 2026 updated by: Washington University School of Medicine
The goal of this study is to learn about brain connectivity and if massaging babies shortly after birth has an impact.
Half of the recruited babies will receive massage daily while the other half will not, and differences will be observed.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Victoria Brooks, LCSW
- Phone Number: (314) 312-2684
- Email: pipproject@wustl.edu
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Recruiting
- University of Minnesota
-
Sub-Investigator:
- Julia Moser
-
Contact:
- Julia Moser
- Phone Number: 612-625-5000
- Email: precisionbaby@umn.edu
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Principal Investigator:
- Chad Sylvester, MD, PhD
-
Contact:
- Victoria Brooks
- Phone Number: 314-312-2684
- Email: victoria.day@wustl.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- English speaking
- Ability to give informed consent
Exclusion Criteria:
- Prisoners (vulnerable population)
- Pregnant women <18 years of age
- Active psychosis, mania, suicidal ideation (safety)
- Active substance dependence
- Gestational Age <35 weeks (neonates)
- Neonatal encephalopathy (neonates)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Neonatal Massage Received
|
caregivers providing therapeutic touch techniques on their neonate
|
|
No Intervention: No Massage Received
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in correlated brain activity among functional brain areas in the somatomotor cortex
Time Frame: up to 3 months
|
Brain activity is measured across the brain with functional magnetic resonance imaging (fMRI) before and after the intervention.
The timeseries of brain activity will be extracted from each of the subject-specific parcels of the somatomotor network (SMN).
Parcels will be divided into those that represent the upper versus lower extremity.
The average of the pairwise correlations in the timeseries between upper and lower extremity parcels is the "cross-effector SMN functional connectivity" that is the primary measure.
This measure will be computed before and after the intervention; we predict a decrease in cross-effector SMN functional connectivity following the intervention.
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2025
Primary Completion (Estimated)
August 1, 2029
Study Completion (Estimated)
July 1, 2030
Study Registration Dates
First Submitted
January 23, 2023
First Submitted That Met QC Criteria
April 24, 2023
First Posted (Actual)
May 6, 2023
Study Record Updates
Last Update Posted (Actual)
August 19, 2026
Last Update Submitted That Met QC Criteria
August 17, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 202404186
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.